Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 22, 2025 10:00 ET | Source: Baylor Genetics

Baylor Genetics to Showcase the Expanding Role and Clinical Value of Genetic Testing in Pediatric Neurology at the 2025 Child Neurology Society Annual Meeting

HOUSTON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it will showcase its leadership in pediatric...
September 18, 2025 09:30 ET | Source: Sevaro Health

After Transforming Neuro Care, Sevaro Secures $39M to Expand AI-Powered Specialty Care Platform

Sevaro secures $39M in Series B funding to expand AI-powered platform—advancing virtual neurology and specialty care nationwide.
$European Refractory Epilepsy Treatment Market$

September 16, 2025 06:43 ET | Source: Research and Markets

Europe Refractory Epilepsy Treatment Research Report 2025 | Market to More Than Double to Reach $2.82 Billion by 2035, Driven by CBD Growth, Uptake of Neuromodulation Therapies, Strong R&D Pipeline

Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Europe Refractory Epilepsy Treatment Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The Europe...
$Asia-Pacific Refractory Epilepsy Treatment Market$

September 16, 2025 06:25 ET | Source: Research and Markets

Asia-Pacific Refractory Epilepsy Treatment Market Research 2025 | Market to Reach $2.48 Billion by 2035 - Opportunities Fueled by a Shift from Neo-Adjuvant Approaches Driven by Diagnostic Advancements

Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Refractory Epilepsy Treatment Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The...
September 04, 2025 13:35 ET | Source: Avania

Avania Strengthens Leadership Team with Appointment of Four New Executives

BILTHOVEN, Netherlands and BOSTON, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Avania, the leading global MedTech advisory and clinical development partner, is pleased to announce strategic leadership...
August 26, 2025 03:00 ET | Source: PannTheraPi

PannTheraPi se prépare pour mener son premier essai clinique de phase IIa avec le PTI5803 chez des patients atteints d'épilepsie résistante et accélérer le développement de son portefeuille propriétaire

PannTheraPi se prépare pour mener son premier essai clinique de phase IIa avec le PTI5803 chez des patients atteints d'épilepsie résistante et accélérer le développement de son portefeuille...
August 26, 2025 03:00 ET | Source: PannTheraPi

PannTheraPi prepares plans to conduct its first Phase IIa clinical trial with PTI5803 in patients with resistant epilepsy and accelerate the development of its proprietary pipeline

PannTheraPi prepares plans to conduct its first Phase IIa clinical trial with PTI5803 in patients with resistant epilepsy and accelerate the development of its proprietary pipeline Pre-submission...
August 06, 2025 10:00 ET | Source: Centre for Neuro Skills

Brain Injury Association of America to Honor Centre for Neuro Skills’ Dr. Mark Ashley as Luminary of the Year

Brain Injury Association of America honors Centre for Neuro Skills' Dr. Mark Ashley as 2025 Luminary of the Year for contributions in brain injury field
July 30, 2025 07:25 ET | Source: ALTERITY THERAPEUTICS LIMITED

Appendix 4C – Q4 FY25 Quarterly Cash Flow Report

Highlights Granted U.S. FDA Fast Track Designation for ATH434 to treat Multiple System Atrophy (MSA)Reported positive topline data from open-label Phase 2 clinical trial of ATH434 in MSAPresented...
July 29, 2025 12:00 ET | Source: CorTec GmbH

CorTec Announces Neurotech Milestone: First Human Implantation of a Brain-Computer Interface made in Germany

FREIBURG, Germany, July 29, 2025 (GLOBE NEWSWIRE) -- CorTec GmbH, a pioneer in active implantable medical technologies, today announced the first human implantation of its proprietary BCI system,...